Gut Microbiome

Endotoxins and Metabolic Endotoxemia in Obesity and Associated Noncommunicable Diseases: A Focus on Sex Differences.

TL;DR

Metabolic endotoxemia, driven by gut dysbiosis and impaired barrier function, is proposed as a mechanism linking inflammation to obesity and associated noncommunicable diseases, with most influencing factors exhibiting sexual dimorphism that warrants consideration in future prevention strategies.

Key Findings

Gut dysbiosis is a hallmark of obesity and contributes to metabolic endotoxemia through impaired intestinal barrier function.

  • Microbial imbalance and impaired intestinal mucosa allow bacterial endotoxins, specifically lipopolysaccharides (LPS), to translocate from the gut into the bloodstream.
  • Circulating LPS sustain a prolonged, sterile, low-grade inflammation that raises the risk of several noncommunicable diseases.
  • Diet has been reported to regulate both inflammation and disease risk by affecting gut microbiota composition and gut barrier function.

The risk and incidence of obesity and several obesity-associated disorders are sex-specific.

  • Increasing evidence indicates sex differences in the risk and incidence of obesity and associated disorders.
  • The underlying mechanisms of sex differences in obesity-related disease risk are described as 'only just emerging.'
  • Most of the factors influencing metabolic endotoxemia exhibit sexual dimorphism.

Metabolic endotoxemia has been proposed as a possible mechanism to explain the link between inflammation, obesity, and obesity-associated disorders.

  • The review focuses on human studies investigating the role of metabolic endotoxemia in obesity and associated diseases.
  • Circulating endotoxins are discussed as having clinical relevance in metabolic derangements.
  • Endotoxins are identified as potential sex-related and modifiable risk factors to consider in future prevention strategies.

Circulating endotoxins are discussed as potential sex-related and modifiable risk factors relevant to metabolic derangements.

  • The review highlights the potential role of circulating endotoxins in prevention strategies.
  • Sex differences in metabolic endotoxemia are emphasized as a focus area for future research.
  • The authors discuss the clinical relevance of circulating endotoxins specifically in the context of metabolic derangements associated with obesity.

Most factors influencing metabolic endotoxemia exhibit sexual dimorphism.

  • Sexual dimorphism is noted across most of the factors that influence metabolic endotoxemia.
  • This sexual dimorphism is identified as a notable and recurring theme across the reviewed literature.
  • The review specifically aims to summarize human studies highlighting sex differences in metabolic endotoxemia and associated diseases.

Have a question about this study?

Citation

Del Cornò M, Aureli A, Varano B, Conti L. (2026). Endotoxins and Metabolic Endotoxemia in Obesity and Associated Noncommunicable Diseases: A Focus on Sex Differences.. Biomolecules. https://doi.org/10.3390/biom16020226